A61M2230/202

TECHNIQUES FOR DETERMINING ACID-BASE HOMEOSTASIS

The described technology may include processes to model acid-base homeostasis in normal patients and under acid-base disorder conditions. In one embodiment, a method may include an acid-base homeostasis analysis process. The method may include, via a processor of a computing device, providing an acid-base model configured to model acid-base homeostasis of a patient, the acid-base model comprising a patient model, a dialyzer model, and an extracorporeal CO.sub.2 removal device (ECCO.sub.2RD), and determining predicted patient information using the acid-base model. Other embodiments are described.

DEVICE FOR TREATING AN INDIVUDUAL SUFFERING FROM CARDIAC INSUFFICIENCY, CARDIAC ARREST, CIRCULATORY ARREST OR STROKE
20220257861 · 2022-08-18 ·

The invention relates to a device for treating an individual suffering from cardiac or circulatory arrest or from a stroke, comprising a blood withdrawal device (BE) that is applied to the individual (P), an analysis unit (BA) which is directly or indirectly connected to the blood withdrawal device for detecting a blood analysis result (BAE) providing at least one characteristic of the blood, directly or indirectly connected to a blood return device (BR) that is applied to the individual (P) and is designed to deliver a substance to the individual via the return device (BR).

Non-invasive device for synchronizing chest compression and ventilation parameters to residual myocardial activity during cardiopulmonary resuscitation

A system for improving cardiac output of a patient suffering from pulseless electrical activity or shock and yet displays myocardial wall motion including: a sensor to detect myocardial activity to determine the presence of residual left ventricular pump function having a contraction or ejection phase and a filling or relaxation phase, a device to prompt the application of or apply a compressive force repeatedly applied to the chest based on the sensed myocardial activity such that the compressive force is applied during at least some of the ejection phases and is ceased during at least some of the relaxation phases to permit residual cardiac filling, thereby enhancing cardiac output and organ perfusion.

FLOW MIXERS FOR RESPIRATORY THERAPY SYSTEMS

A flow of gases in a respiratory therapy system can be conditioned to achieve more consistent output from sensors configured to sense a characteristic of the flow. The flow can be mixed by imparting a tangential, rotary, helical, or swirling motion to the flow of gases. The mixing can occur upstream of the sensors. The flow can be segregated into smaller compartments to reduce turbulence in a region of the sensors.

Positive expiratory pressure device

A positive exhalation pressure device increases the pressure gradient in the airways, thereby increasing oxygen saturation levels and decreasing the severity of hypoxia. Various embodiments of the device may be inserted into the nasal and/or oral cavities, or configured as mask devices covering the nasal and/or oral cavities. In some embodiments, the resistance of the device may be varied.

Systems and methods for patient cardiovascular and respiratory management
11446438 · 2022-09-20 ·

An information display and control system that enables a fast and easy understanding and management of the status of the patient's dialysis is disclosed. Also disclosed is an information display and control system that enables a fast and easy understanding and management of the status of the patient's cardiovascular and ventilation systems. The system can control management of a patient's dialysis, as well as administration and management of a patient's medication and fluids. The display is organized by goals related to management of patient's dialysis machine, blood flow, dialyzer flow, and patient's body weight. The display is also organized by goals related to management of patient's cardiovascular system, ventilation system, and medications and fluids administration and management. Such goals include urea reduction rate, urea reduction ratio, fractional urea clearance, total urea reduction, dialysis treatment duration, hemodynamics, oxygenation, CO.sub.2 removal, medication status, and fluids status.

METHOD FOR EXTRACORPOREAL CARBON DIOXIDE REMOVAL
20220249753 · 2022-08-11 · ·

Described herein is a process suitable for extracorporeal lung support that relies on exposing blood, separated by a semipermeable membrane from the dialysis liquid. The dialysis liquid comprises a buffering agent and has a high buffering capacity for H+ ions. Carbon dioxide, bicarbonate and hydrogen cations can be efficiently transported across a semipermeable membrane to the dialysis liquid. This also allows for the regeneration and recycling of the dialysis liquid, and thus for its repeated use. The versatility of the dialysis liquid allows adjusting the pill of the dialysis liquid, add fluids to the dialysis liquid and/or to the blood in the extracorporeal circuit and to remove substances from the blood in the extracorporeal circuit, depending on the conditions and needs. Thus, the process is versatile, and suitable for treating or preventing respiratory acidosis, metabolic acidosis, diseases associated with lung malfunction and/or kidney malfunction and/or liver malfunction.

Ventilation system

A ventilator system includes a ventilation device, and is configured to operate in a passive mode configured to transmit ventilation data in response to requests from a ventilation management system, or an active mode configured to automatically transmit ventilation data as the data becomes available. The system receives ventilation system data associated with operation of the ventilation device, modifies one or more operating parameters of the ventilation device based on the received ventilation system data, receives ventilator data associated with the ventilator device, determines an alarm associated with the ventilator device or a patient based on the received ventilator data and, responsive to determining the alarm, sends the alarm to a beginning of a transmission queue for transmitting the ventilation data to the ventilation management system, wherein the alarm is communicated over the network prior to other ventilation data in the transmission queue.

Devices and methods for sleep disorder diagnosis and treatment

The present invention relates to an integrated sleep diagnosis and treatment device, and more particularly to an integrated apnea diagnosis and treatment device. The present invention additionally relates to method of sleep diagnosis and treatment.

USER INTERFACE FOR A THERAPY DEVICE
20220244839 · 2022-08-04 · ·

A medical therapy device may include a user interface (6100) such as a combined touchscreen/dial user interface, for input of operation parameters. The user interface may include a dial and a touchscreen to display a subset of a list of items. Each item may represent a parameter of the medical device. The displayed subset may include a pre-selected item that may provide a pre-selection indication for a particular item. Rotation of the dial may move the pre-selection indication so it may change between items on the displayed subset. In response to a swipe gesture on the touchscreen, the displayed subset may scroll through the list. Also, the swipe gesture may cause pushing of the pre-selection indication against a boundary of the display such as in the direction of the swipe gesture such that the item associated with the pre-selection indication remains part of the displayed subset.